-
Mashup Score: 2Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer - 3 year(s) ago
Abstract. Castration-resistant prostate cancer (CRPC) is a terminal disease and the molecular underpinnings of CRPC development need to be better understood in
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3New Approach May Boost Prostate Cancer Immunotherapies - 3 year(s) ago
Researchers have discovered a new way to transform the tissues surrounding prostate tumors to help the body’s immune cells fight the cancer. The discovery, made in human and mouse cells and in laboratory mice, could lead to improvements in immunotherapy treatments for prostate cancer, the second most common cancer in men in the U.S.Using a techn…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 18Project Scientist- Leigh Ellis Lab at Cedars-Sinai - 4 year(s) ago
Learn more about applying for Project Scientist- Leigh Ellis Lab at Cedars-Sinai
Source: jobs.cedars-sinai.eduCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer. - PubMed - NCBI - 4 year(s) ago
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Source: www.ncbi.nlm.nih.govCategories: Hem/OncsTweet
Important finding for #ProstateCancer involving former #EllisLab alumni @pmgalbo @PCF_Science #chromatin https://t.co/b1HBDhTXeb